Organism 49499 - Balanites aegyptiaca (ZYGOPHYLLACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Search for all experiments on this taxon

Organism Details

Property	Value
Taxon	4270
Family	ZYGOPHYLLACEAE
Genus	BALANITES
Species	AEGYPTIACA
Species authority	(L.) DELILE
Subspecies
Subspecies authority
Comment
Citation	KAMEL,MS: OHTANI,K: KUROKAWA,T: ASSAF,MH: EL-SHANAWANY,MA: ALI,AA: KASAI,R: ISHIBASHI,S: TANAKA,O:. (1991). STUDIES ON BALANITES AEGYPTIACA FRUITS, AN ANTIDIABETIC EGYPTIAN FOLK MEDICINE.. 39(5)
Geographical area	NORTHERN AFRICA
Country	EGYPT

Experiments

18 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
121547	MEDICINAL FOLKLORE REPORTED FOR	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)
121548	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)
121549	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
121550	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
121551	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAHPLC SEPARATION DATA FORTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
121552	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-(2-4-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
121553	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-(ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOSIDE
121554	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-22-26-TRIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 3-O-(ALPHA-L-RHAMNOPYRANOSYL(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-(ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOSIDE
121555	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOPYSIDE
121556	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	FUROST-5-ENE-3-BETA-26-DIOL,26-O-BETA-D-GLUCOPYRANOSYL-(25R): 22-O-METHYL: 3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2))-(BETA-D-XYLOPYRANOSYL(1-3))-ALPHA-L-RHAMNOPYRANOSYL(1-4))BETA-D-GLUCOPYSIDE
121557	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 5
121558	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 5
121559	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 6
121560	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 6
121561	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 7
121562	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 7
121563	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORTLC DATA REPORTED		Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 8
121564	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Balanites aegyptiaca (ZYGOPHYLLACEAE)	CHOLESTADIENE GLYCOSIDE 8

Organism 49499 - Balanites aegyptiaca (ZYGOPHYLLACEAE)

Organism Details

Experiments

Filters

Worktypes (11)

Pharmacology (2)

Compounds (9)

Show SPARQL Queries (1)

Query 1